Literature DB >> 8809160

Design, synthesis, and evaluation of 2 beta-alkenyl penam sulfone acids as inhibitors of beta-lactamases.

H G Richter1, P Angehrn, C Hubschwerlen, M Kania, M G Page, J L Specklin, F K Winkler.   

Abstract

A general method for synthesis of 2 beta-alkenyl penam sulfones has been developed. The new compounds inhibited most of the common types of beta-lactamase. The level of activity depended very strongly on the nature of the substituent in the 2 beta-alkenyl group. The inhibited species formed with the beta-lactamase from Citrobacter freundii 1205 was sufficiently stable for X-ray crystallographic studies. These, together with UV absorption spectroscopy and studies of chemical degradation, suggested a novel reaction mechanism for the new inhibitors that might account for their broad spectrum of action. The (Z)-2 beta-acrylonitrile penam sulfone Ro 48-1220 was the most active inhibitor from this class of compound. The inhibitor enhanced the action of, for example, ceftriaxone against a broad selection of organisms producing beta-lactamases. The organisms included strains of Enterobacteriaceae that produce cephalosporinases, which is an exceptional activity for penam sulfones.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8809160     DOI: 10.1021/jm9601967

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  12 in total

1.  A novel type of AmpC beta-lactamase, ACC-1, produced by a Klebsiella pneumoniae strain causing nosocomial pneumonia.

Authors:  A Bauernfeind; I Schneider; R Jungwirth; H Sahly; U Ullmann
Journal:  Antimicrob Agents Chemother       Date:  1999-08       Impact factor: 5.191

2.  Use of beta-lactamase inhibitors in disk tests to detect plasmid-mediated AmpC beta-lactamases.

Authors:  Jennifer A Black; Kenneth S Thomson; Johann D D Pitout
Journal:  J Clin Microbiol       Date:  2004-05       Impact factor: 5.948

3.  Comparative evaluation of the inhibitory activities of the novel penicillanic acid sulfone Ro 48-1220 against beta-lactamases that belong to groups 1, 2b, and 2be.

Authors:  L S Tzouvelekis; M Gazouli; E E Prinarakis; E Tzelepi; N J Legakis
Journal:  Antimicrob Agents Chemother       Date:  1997-02       Impact factor: 5.191

4.  Evaluation of beta-lactamase inhibitors in disk tests for detection of plasmid-mediated AmpC beta-lactamases in well-characterized clinical strains of Klebsiella spp.

Authors:  Jennifer A Black; Kenneth S Thomson; John D Buynak; Johann D D Pitout
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

Review 5.  Current challenges in antimicrobial chemotherapy: focus on ß-lactamase inhibition.

Authors:  Carine Bebrone; Patricia Lassaux; Lionel Vercheval; Jean-Sébastien Sohier; Adrien Jehaes; Eric Sauvage; Moreno Galleni
Journal:  Drugs       Date:  2010-04-16       Impact factor: 9.546

6.  Salmonella enteritidis: AmpC plasmid-mediated inducible beta-lactamase (DHA-1) with an ampR gene from Morganella morganii.

Authors:  G Barnaud; G Arlet; C Verdet; O Gaillot; P H Lagrange; A Philippon
Journal:  Antimicrob Agents Chemother       Date:  1998-09       Impact factor: 5.191

7.  Synergistic antibacterial effects of herbal extracts and antibiotics on methicillin-resistant Staphylococcus aureus: A computational and experimental study.

Authors:  Chiu-Fai Kuok; Sai-On Hoi; Chi-Fai Hoi; Chi-Hong Chan; Io-Hong Fong; Cheong-Kei Ngok; Li-Rong Meng; Pedro Fong
Journal:  Exp Biol Med (Maywood)       Date:  2017-01-01

Review 8.  Three decades of beta-lactamase inhibitors.

Authors:  Sarah M Drawz; Robert A Bonomo
Journal:  Clin Microbiol Rev       Date:  2010-01       Impact factor: 26.132

9.  Inhibition of OXA-1 beta-lactamase by penems.

Authors:  Christopher R Bethel; Anne M Distler; Mark W Ruszczycky; Marianne P Carey; Paul R Carey; Andrea M Hujer; Magda Taracila; Marion S Helfand; Jodi M Thomson; Matthew Kalp; Vernon E Anderson; David A Leonard; Kristine M Hujer; Takao Abe; Aranapakam M Venkatesan; Tarek S Mansour; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2008-06-16       Impact factor: 5.191

Review 10.  New treatment options against gram-negative organisms.

Authors:  Matteo Bassetti; Francesca Ginocchio; Malgorzata Mikulska
Journal:  Crit Care       Date:  2011-03-22       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.